慢性鼻-鼻窦炎的内在型:从基础到临床

doi:10.6040/j.issn.1673-3770.1.2017.054

摘要/Abstract

摘要： 慢性鼻-鼻窦炎(CRS)是多因素作用下鼻及鼻窦黏膜的慢性持续性炎症,具有高度异质性,病理机制非常复杂,临床表现型相同,其内在型和预后可能不同。CRS内在型是对不同个体CRS发病内在本质的研究,是从细胞和分子生物学角度探索疾病的发病本质,随着CRS内在型研究的不断深入,期望能找到某些特定的分子标志物,以这些分子标志物为靶标实现个体化的精准治疗。

关键词: 精准治疗, 慢性, 分子生物学, 鼻-鼻窦炎

Abstract: Chronic rhinosinusitis(CRS)is a complex disease that involves multiple factors and is characterized by chronic persistent inflammation of the nasal and sinus mucosa. Owing to the high heterogeneity and complicated pathological mechanism, polyps of different endotypes may exhibit the same phenotype. The present research on the endotype of chronic rhinosinusitis focuses on the cellular and molecular biology aspects of the disease onset. We expect to identify specific molecular markers, which can be used as target molecules for accurate individualized treatment.

Key words: Accurate treatment, Molecular biology, Rhinosinusitis, chronic

中图分类号:

R765.4

张桂敏,林鹏. 慢性鼻-鼻窦炎的内在型:从基础到临床[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 14-17.

ZHANG Guimin, LIN Peng. Endotype of chronic rhinosinusitis: from basic to clinical research[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 14-17.

参考文献

[1] 周兵, 韩德民.鼻内镜外科基本技术的再认识与发展[J]. 中华耳鼻咽喉头颈外科杂志, 2011, 46(6):441-443.
[2] Bachert C, Holtappels G. Pathophysiology of chronic rhinosinusitis, pharmaceutical therapy options[J]. GMS Curr Top Otorhinolaryngol Head Neck Surg, 2015, 14:Doc09. DOI:10.3205/cto000124.
[3] Gevaert P, Lang-Loidolt D, Lackner A, et al. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps[J]. J Allergy Clin Immunol, 2006, 118(5):1133-1141.
[4] Gevaert P, Van BN, Cattaert T, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis[J]. J Allergy Clin Immunol, 2011, 128(5):989-995.
[5] Gevaert P, Calus L, Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma[J]. J Allergy Clin Immunol, 2013, 131(1):110-116.
[6] Lane AP, Truongtran QA, Schleimer RP.Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps[J]. Am J Rhinol, 2006, 20(2):138-144.
[7] Adappa ND, Zhang Z, Palmer JN, et al. The bitter taste receptor T2R38 is an independent risk factor for chronic rhinosinusitis requiring sinus surgery[J]. Int Forum Allergy Rhinol, 2014, 4(1):3-7.
[8] Lee RJ, Cohen NA.The emerging role of the bitter taste receptor T2R38 in upper respiratory infection and chronic rhinosinusitis[J]. Am J Rhinol Allergy, 2013, 27(4):283-286.
[9] Nagarkar DR, Poposki JA, Tan BK, et al. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2013, 132(3):593-600.
[10] Baba S, Kondo K, Kanaya K, et al. Expression of IL-33 and its receptor ST2 in chronic rhinosinusitis with nasal polyps[J]. Laryngoscope, 2014, 124(4):E115-122.
[11] Lam M, Hull L, Mclachlan R, et al. Clinical severity and epithelial endotypes in chronic rhinosinusitis[J]. Int Forum Allergy Rhinol, 2013, 3(2):121-128.
[12] Lam M, Hull L, Imrie A, et al. Interleukin-25 and interleukin-33 as mediators of eosinophilic inflammation in chronic rhinosinusitis[J]. Am J Rhinol Allergy, 2015, 29(3):175-178.
[13] Yao T, Kojima Y, Koyanagi A, et al. Eotaxin-1, -2, and-3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients[J]. Laryngoscope, 2009, 119(6):1053-1059.
[14] Divekar R, Kita H.Recent advances in epithelium-derived cytokines(IL-33, IL-25, and thymic stromal lymphopoietin)and allergic inflammation[J]. Curr Opin Allergy Clin Immunol, 2015, 15(1):98-103.
[15] Lam M, Hull L, Mclachlan R, et al. Clinical severity and epithelial endotypes in chronic rhinosinusitis[J]. Int Forum Allergy Rhinol, 2013, 3(2):121-128.
[16] Shin HW, Kim DK, Park MH, et al. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2015, 135(6):1476-1485.
[17] Kato A, Favoreto S, Avila PC, et al. TLR3-and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells[J]. J Immunol, 2007, 179(2):1080-1087.
[18] Lee HC, Ziegler SF. Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaB[J]. Proc Natl Acad Sci U S A, 2007, 104(3):914-919.
[19] Boita M, Garzaro M, Raimondo L, et al. Eosinophilic inflammation of chronic rhinosinusitis with nasal polyps is related to OX40 ligand expression[J]. Innate Immun, 2015, 21(2):167-174.
[20] Liu T, Li TL, Zhao F, et al. Role of thymic stromal lymphopoietin in the pathogenesis of nasal polyposis[J]. Am J Med Sci, 2011, 341(1):40-47.
[21] Mjösberg JM, Trifari S, Crellin NK, et al. Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161[J]. Nat Immunol, 2011, 12(11):1055-1062.
[22] Robinette ML, Colonna M.Immune modules shared by innate lymphoid cells and T cells[J]. J Allergy Clin Immunol, 2016, 138(5):1243-1251.
[23] Morita H, Moro K, Koyasu S. Innate lymphoid cells in allergic and nonallergic inflammation[J]. J Allergy Clin Immunol, 2016, 138(5):1253-1264.
[24] Bal SM, Bernink JH, Nagasawa M, et al. IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs[J]. Nat Immunol, 2016, 17(6):636-645.
[25] Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators[J]. Allergy, 2006, 61(11):1280-1289.
[26] Zhang N, Van ZT, Pereznovo C, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease[J]. J Allergy Clin Immunol, 2008, 122(5):961-968.
[27] Wang X, Zhang N, Bo M, et al. Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania[J]. J Allergy Clin Immunol, 2016, 138(5):1344-1353.
[28] Tomassen P, Vandeplas G, Van Zele T, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers[J]. J Allergy Clin Immunol, 2016, 137(5):1449-1456.
[29] Kim JW, Hong SL, Kim Yk, et al. Histological and immunological features of non-eosinophilic nasal polyps[J]. Otolaryngol Head Neck Surg, 2007, 137(6):925-930.
[30] Ba L, Zhang N, Meng J, et al. The association between bacterial colonization and inflammatory pattern in Chinese chronic rhinosinusitis patients with nasal polyps[J]. Allergy, 2011, 66(10):1296-1303.
[31] Orlandi RR, Kingdom TT, Hwang PH. International consensus statement on allergy and rhinology: rhinosinusitis executive summary[J]. Int Forum Allergy Rhinol, 2016. DOI: 10.1002/alr.21694.
[32] Sommer DD, Rotenberg BW, Sowerby LJ, et al. A novel treatment adjunct for aspirin exacerbated respiratory disease:the low-salicylate diet:a multicenter randomized control crossover trial[J]. Int Forum Allergy Rhinol, 2016, 6(4):385-391.
[33] Cingi C, Muluk NB, Ipci K, et al. Antileukotrienes in upper airway inflammatory diseases[J]. Curr Allergy Asthma Rep, 2015, 15(11):64.
[34] Laidlaw TM, Kidder MS, Bhattacharyya N, et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes[J]. Blood, 2012, 119(16):3790-3798.

相关文章 15

[1]	冯思聪,于晓岚,娄丹. 基于囊泡组织Ki67、GM-CSF表达评估Messerklinger中鼻甲成形术对慢性鼻-鼻窦炎合并鼻息肉的效果[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 31-39.
[2]	翟雪纯,边欣,陈敬彩,邓家钰,叶子,杨萍丽. 慢性额窦炎患者焦虑抑郁特点及横断面研究[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 35-43.
[3]	吉睿,刘雅洁,王佳琪,史雅文,张炜明,殷敏. 慢性间歇性缺氧对大鼠茎突舌肌的影响及作用机制[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 44-48.
[4]	段思妤,薛金梅. 组蛋白去乙酰化酶2在慢性气道炎症性疾病糖皮质激素抵抗中的研究进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 120-126.
[5]	李阳松,袁发洋,杨艳,张田,喻国冻. 基于Web of Science进行生物制剂治疗慢性鼻窦炎文献计量学分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 54-64.
[6]	杜康丽,郑振宇,徐战将,张宇,陈露,卢梦垚. 鼻中隔偏曲并发慢性鼻窦炎风险预测模型的构建与验证[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 78-86.
[7]	熊琴, 张砚, 乌日娜, 李锋, 唐力行. 鼻用糖皮质激素在儿童中的应用[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 160-167.
[8]	董雪林,张治军. 掩蔽声治疗慢性主观性耳鸣的焦虑抑郁状态分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 18-24.
[9]	张广玲,陈兴雪,武天义,孙占伟,王卫卫,李世超,王广科. Tespa1在慢性鼻窦炎伴鼻息肉中的表达及作用研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 35-42.
[10]	曹正勇,李小波. 慢性鼻-鼻窦炎合并哮喘术后短程局部使用糖皮质激素辅助治疗的安全性和有效性[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 43-50.
[11]	周荷青,申琪. 中医药治疗变应性鼻炎疗效的生物标志物研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 168-176.
[12]	郭振平,李雪冰. 慢性主观性耳鸣患者心理特征、睡眠质量调查及与临床效果相关性[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 1-7.
[13]	王文晴,张丹,朱梦迪,王路阳,杨培培,孙思思,张秋敏,周慧. 慢性鼻窦炎伴鼻息肉复发手术时临床及组织病理学特征变化[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 46-53.
[14]	王奥维,时文杰. CRSwNP中医证型与TFH细胞相关因子的相关性研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 54-60.
[15]	张婕,尼玛吉宗,徐小东,周菁,刘建敏,罗依蕤,杜进涛,巴罗. 藏红花素在嗜酸性慢性鼻窦炎伴鼻息肉中调控2型炎症反应的研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 61-67.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed